SE8403905D0 - Liposomes and steroid esters - Google Patents

Liposomes and steroid esters

Info

Publication number
SE8403905D0
SE8403905D0 SE8403905A SE8403905A SE8403905D0 SE 8403905 D0 SE8403905 D0 SE 8403905D0 SE 8403905 A SE8403905 A SE 8403905A SE 8403905 A SE8403905 A SE 8403905A SE 8403905 D0 SE8403905 D0 SE 8403905D0
Authority
SE
Sweden
Prior art keywords
sub
liposomes
sup
compounds
inflammatory conditions
Prior art date
Application number
SE8403905A
Other languages
English (en)
Inventor
B I Axelsson
R L Brattsand
C M O Dahlbeck
L A Kellstrom
J W Trofast
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of SE8403905D0 publication Critical patent/SE8403905D0/sv
Priority to SE8403905A priority Critical patent/SE8403905D0/sv
Application filed by Draco Ab filed Critical Draco Ab
Priority to AT85850222T priority patent/ATE60990T1/de
Priority to DE8585850222T priority patent/DE3581856D1/de
Priority to EP85850222A priority patent/EP0170642B1/en
Priority to ZA855032A priority patent/ZA855032B/xx
Priority to NO852672A priority patent/NO168042C/no
Priority to US06/752,257 priority patent/US4693999A/en
Priority to IS3026A priority patent/IS1515B/is
Priority to PH32544A priority patent/PH21644A/en
Priority to NZ212861A priority patent/NZ212861A/xx
Priority to AU45307/85A priority patent/AU582173B2/en
Priority to DK336385A priority patent/DK164509C/da
Priority to SU853929451A priority patent/SU1493111A3/ru
Priority to PL1985254681A priority patent/PL145673B1/pl
Priority to CN 85105713 priority patent/CN1017402B/zh
Priority to PT80884A priority patent/PT80884B/pt
Priority to EG448/85A priority patent/EG17462A/xx
Priority to FI852932A priority patent/FI84914C/sv
Priority to CS855542A priority patent/CS254342B2/cs
Priority to HU852859A priority patent/HU196827B/hu
Priority to CA000487649A priority patent/CA1250830A/en
Priority to DD85279092A priority patent/DD236535A5/de
Priority to JP60166063A priority patent/JPS6143110A/ja
Priority to ES545651A priority patent/ES8704969A1/es
Priority to KR1019850005440A priority patent/KR930000045B1/ko
Priority to IE189285A priority patent/IE58074B1/en
Priority to DD85292279A priority patent/DD248055A5/de
Priority to YU123885A priority patent/YU45735B/sh
Priority to SI8511238A priority patent/SI8511238A8/sl
Priority to ES557143A priority patent/ES8705895A1/es
Priority to HR920587A priority patent/HRP920587A2/hr
Priority to SG690/93A priority patent/SG69093G/en
Priority to LV930864A priority patent/LV5527A3/xx
Priority to HK782/93A priority patent/HK78293A/xx
Priority to LTRP951A priority patent/LT2257B/xx
Priority to CY173194A priority patent/CY1731A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
SE8403905A 1984-07-30 1984-07-30 Liposomes and steroid esters SE8403905D0 (sv)

Priority Applications (36)

Application Number Priority Date Filing Date Title
SE8403905A SE8403905D0 (sv) 1984-07-30 1984-07-30 Liposomes and steroid esters
AT85850222T ATE60990T1 (de) 1984-07-30 1985-06-28 Steroidester enthaltende liposome.
DE8585850222T DE3581856D1 (de) 1984-07-30 1985-06-28 Steroidester enthaltende liposome.
EP85850222A EP0170642B1 (en) 1984-07-30 1985-06-28 Liposomes containing steroid esters
ZA855032A ZA855032B (en) 1984-07-30 1985-07-03 Liposomes containing steroid esters
NO852672A NO168042C (no) 1984-07-30 1985-07-03 Analogifremgangsmaate for fremstilling av terapeutisk aktive steroidestere
US06/752,257 US4693999A (en) 1984-07-30 1985-07-03 Liposomes containing steroid esters
IS3026A IS1515B (is) 1984-07-30 1985-07-09 Lípósóm sem innihalda steroíð-estera
PH32544A PH21644A (en) 1984-07-30 1985-07-19 Liposomes containing steroid esters
NZ212861A NZ212861A (en) 1984-07-30 1985-07-24 Steroids and pharmaceutical compositions
AU45307/85A AU582173B2 (en) 1984-07-30 1985-07-24 Liposomes containing steroid esters
DK336385A DK164509C (da) 1984-07-30 1985-07-24 Hidtil ukendte steroidforbindelser og fremgangsmaade til fremstilling af samme samt farmaceutisk praeparat til indgift i luftvejene
SU853929451A SU1493111A3 (ru) 1984-07-30 1985-07-25 Способ получени стероидных сложных эфиров
PL1985254681A PL145673B1 (en) 1984-07-30 1985-07-25 Method of obtaining novel stereoidic esters
CN 85105713 CN1017402B (zh) 1984-07-30 1985-07-27 含有甾族化合物类固醇酯的脂质体的制备方法
EG448/85A EG17462A (en) 1984-07-30 1985-07-29 Liposomes and steroid esters
DD85292279A DD248055A5 (de) 1984-07-30 1985-07-29 Verfahren zur herstellung eines pharmazeutischen praeparates
PT80884A PT80884B (pt) 1984-07-30 1985-07-29 Processo para a preparacao de novos esteres de esteroides e de composicoes farmaceuticas contendo liposomas que incluem este esteres
FI852932A FI84914C (sv) 1984-07-30 1985-07-29 Förfarande för framställning av farmakologiskt aktiva steroidestrar
CS855542A CS254342B2 (en) 1984-07-30 1985-07-29 Method of new steroid compounds production
HU852859A HU196827B (en) 1984-07-30 1985-07-29 Process for producing steroid esters and liposomes comprising the same
CA000487649A CA1250830A (en) 1984-07-30 1985-07-29 Liposomes containing steroid esters
DD85279092A DD236535A5 (de) 1984-07-30 1985-07-29 Verfahren zur herstellung von steroidestern
JP60166063A JPS6143110A (ja) 1984-07-30 1985-07-29 ステロイドエステルを含有するリポソーム
ES545651A ES8704969A1 (es) 1984-07-30 1985-07-29 Un procedimiento para preparar esteres de esteroides.
KR1019850005440A KR930000045B1 (ko) 1984-07-30 1985-07-29 스테로이드 에스테르류를 함유하는 리포솜의 제조 방법
IE189285A IE58074B1 (en) 1984-07-30 1985-07-29 Liposomes containing steroid esters
YU123885A YU45735B (sh) 1984-07-30 1985-07-30 Postupak za dobijanje farmaceutskog preparata za primarno davanje u respiratorni trakt
SI8511238A SI8511238A8 (sl) 1984-07-30 1985-07-30 Postopek za pridobivanje farmacevtskega pripravka za primarno dajanje v respiratorni trakt
ES557143A ES8705895A1 (es) 1984-07-30 1986-10-23 Un procedimiento para preparar una composicion farmaceutica que comprende liposomas
HR920587A HRP920587A2 (en) 1984-07-30 1992-10-01 Liposomes containing steroid esters a process for the preparation of stable camomile extract rich with active substances
SG690/93A SG69093G (en) 1984-07-30 1993-05-27 Liposomes containing steroid esters
LV930864A LV5527A3 (lv) 1984-07-30 1993-06-30 Panemiens steroidu esteru iegusanai
HK782/93A HK78293A (en) 1984-07-30 1993-08-05 Liposomes containing steroid esters
LTRP951A LT2257B (lt) 1984-07-30 1993-09-06 Steroidu esteriu gavimo budas
CY173194A CY1731A (en) 1984-07-30 1994-05-06 Liposomes containing steroid esters

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8403905A SE8403905D0 (sv) 1984-07-30 1984-07-30 Liposomes and steroid esters

Publications (1)

Publication Number Publication Date
SE8403905D0 true SE8403905D0 (sv) 1984-07-30

Family

ID=20356623

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8403905A SE8403905D0 (sv) 1984-07-30 1984-07-30 Liposomes and steroid esters

Country Status (29)

Country Link
US (1) US4693999A (sv)
EP (1) EP0170642B1 (sv)
JP (1) JPS6143110A (sv)
KR (1) KR930000045B1 (sv)
AT (1) ATE60990T1 (sv)
AU (1) AU582173B2 (sv)
CA (1) CA1250830A (sv)
CS (1) CS254342B2 (sv)
CY (1) CY1731A (sv)
DD (2) DD236535A5 (sv)
DE (1) DE3581856D1 (sv)
DK (1) DK164509C (sv)
EG (1) EG17462A (sv)
ES (2) ES8704969A1 (sv)
FI (1) FI84914C (sv)
HK (1) HK78293A (sv)
HU (1) HU196827B (sv)
IE (1) IE58074B1 (sv)
IS (1) IS1515B (sv)
NO (1) NO168042C (sv)
NZ (1) NZ212861A (sv)
PH (1) PH21644A (sv)
PL (1) PL145673B1 (sv)
PT (1) PT80884B (sv)
SE (1) SE8403905D0 (sv)
SG (1) SG69093G (sv)
SU (1) SU1493111A3 (sv)
YU (1) YU45735B (sv)
ZA (1) ZA855032B (sv)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
SE8501693D0 (sv) * 1985-04-04 1985-04-04 Draco Ab Novel 16,17-acetalsubstituted androstane-17beta-carboxylic acid esters
SE8506015D0 (sv) * 1985-12-19 1985-12-19 Draco Ab Novel 16,17-acetalsubstituted pregnane 21-oic acid derivatives
SE8601457D0 (sv) * 1986-04-01 1986-04-01 Draco Ab Compositions of liposomes and b?712-receptor active substances for inhalation
US5811119A (en) * 1987-05-19 1998-09-22 Board Of Regents, The University Of Texas Formulation and use of carotenoids in treatment of cancer
US5690954A (en) * 1987-05-22 1997-11-25 Danbiosyst Uk Limited Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
FR2619505B1 (fr) * 1987-08-20 1990-08-31 Dior Christian Parfums Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la pregnenolone ou un ester de pregnenolone, et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite regeneratrice ou revitalisante, l'incorporant
GB8723846D0 (en) * 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
EP0397774A1 (en) * 1988-02-04 1990-11-22 Board Of Regents, The University Of Texas System Formulation and use of retinoids in treatment of cancer and other diseases
US4906476A (en) * 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
WO1990006775A1 (en) * 1988-12-14 1990-06-28 Liposome Technology, Inc. A novel nonphospholipid liposome composition for sustained release of drugs
US5043165A (en) * 1988-12-14 1991-08-27 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs
US5100662A (en) * 1989-08-23 1992-03-31 The Liposome Company, Inc. Steroidal liposomes exhibiting enhanced stability
US5922304A (en) 1989-12-22 1999-07-13 Imarx Pharmaceutical Corp. Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
US5776429A (en) * 1989-12-22 1998-07-07 Imarx Pharmaceutical Corp. Method of preparing gas-filled microspheres using a lyophilized lipids
US6001335A (en) * 1989-12-22 1999-12-14 Imarx Pharmaceutical Corp. Contrasting agents for ultrasonic imaging and methods for preparing the same
US5469854A (en) * 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
US6088613A (en) * 1989-12-22 2000-07-11 Imarx Pharmaceutical Corp. Method of magnetic resonance focused surgical and therapeutic ultrasound
US20020150539A1 (en) 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US6551576B1 (en) 1989-12-22 2003-04-22 Bristol-Myers Squibb Medical Imaging, Inc. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5542935A (en) 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US6146657A (en) * 1989-12-22 2000-11-14 Imarx Pharmaceutical Corp. Gas-filled lipid spheres for use in diagnostic and therapeutic applications
US5888995A (en) * 1991-02-04 1999-03-30 Astra Aktiebolag Steroid esters
SE9100341D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroids
SE9100342D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroid esters
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5874062A (en) * 1991-04-05 1999-02-23 Imarx Pharmaceutical Corp. Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
FR2675146A1 (fr) * 1991-04-10 1992-10-16 Roussel Uclaf Nouveaux derives sterouides de la pregna-1,4-diene-3,20-dione, leur preparation, leur application a la preparation de derives 16,17-methylene dioxy substitues et nouveaux intermediaires.
SK87295A3 (en) * 1993-01-08 1996-04-03 Astra Ab Novel colon or ileum-specific steroid derivatives
WO1994028876A1 (en) * 1993-06-07 1994-12-22 Advanced Therapies, Inc. Liposome powders
US7083572B2 (en) 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
US5635206A (en) * 1994-01-20 1997-06-03 Hoffmann-La Roche Inc. Process for liposomes or proliposomes
CH689139A5 (de) * 1995-04-03 1998-10-30 Cerbios Pharma Sa Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung.
US5997898A (en) * 1995-06-06 1999-12-07 Imarx Pharmaceutical Corp. Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
US6231834B1 (en) 1995-06-07 2001-05-15 Imarx Pharmaceutical Corp. Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
US6139819A (en) * 1995-06-07 2000-10-31 Imarx Pharmaceutical Corp. Targeted contrast agents for diagnostic and therapeutic use
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
US6033645A (en) * 1996-06-19 2000-03-07 Unger; Evan C. Methods for diagnostic imaging by regulating the administration rate of a contrast agent
DE69736981D1 (de) 1996-05-01 2007-01-04 Imarx Pharmaceutical Corp In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
TW497974B (en) * 1996-07-03 2002-08-11 Res Dev Foundation High dose liposomal aerosol formulations
US5958378A (en) * 1996-07-03 1999-09-28 Research Development Foundation High dose liposomal aerosol formulations containing cyclosporin A or budesonide
US6414139B1 (en) 1996-09-03 2002-07-02 Imarx Therapeutics, Inc. Silicon amphiphilic compounds and the use thereof
WO1998010798A1 (en) * 1996-09-11 1998-03-19 Imarx Pharmaceutical Corp. Improved methods for diagnostic imaging using a contrast agent and a vasodilator
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
GB2321455A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Lipophilic derivatives of biologically active compounds
US6090800A (en) * 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
US6143276A (en) * 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
US6537246B1 (en) 1997-06-18 2003-03-25 Imarx Therapeutics, Inc. Oxygen delivery agents and uses for the same
WO1998050041A1 (en) * 1997-05-06 1998-11-12 Imarx Pharmaceutical Corp. Novel prodrugs comprising fluorinated amphiphiles
US7452551B1 (en) 2000-10-30 2008-11-18 Imarx Therapeutics, Inc. Targeted compositions for diagnostic and therapeutic use
US6416740B1 (en) 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
US6548047B1 (en) 1997-09-15 2003-04-15 Bristol-Myers Squibb Medical Imaging, Inc. Thermal preactivation of gaseous precursor filled compositions
US6123923A (en) * 1997-12-18 2000-09-26 Imarx Pharmaceutical Corp. Optoacoustic contrast agents and methods for their use
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
US20020061281A1 (en) * 1999-07-06 2002-05-23 Osbakken Robert S. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US6576224B1 (en) * 1999-07-06 2003-06-10 Sinuspharma, Inc. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
CA2386095A1 (en) 1999-09-30 2001-04-05 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment of androgen receptor driven conditions
US20040009229A1 (en) * 2000-01-05 2004-01-15 Unger Evan Charles Stabilized nanoparticle formulations of camptotheca derivatives
WO2001049268A1 (en) * 2000-01-05 2001-07-12 Imarx Therapeutics, Inc. Pharmaceutical formulations for the delivery of drugs having low aqueous solubility
DE10116197A1 (de) * 2001-03-30 2002-10-17 Bernina Biosystems Gmbh Neue Methylprednisolonderivate mit therapeutischer Wirkung
US20050009798A1 (en) 2002-02-20 2005-01-13 Sepracor Inc. Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists
AU2003217535A1 (en) 2002-02-20 2003-09-09 Sepracor Inc. Carbonate and carbamate modified forms of glucocorticoids
AU2003225689B2 (en) * 2002-03-05 2009-03-26 Transave, Inc. Methods for entrapment of bioactive agent in a liposome or lipid complex
US20040235811A1 (en) * 2002-10-08 2004-11-25 Sepracor Inc. Fatty acid modified forms of glucocorticoids
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
EP3427742B1 (en) * 2002-10-29 2020-08-12 Insmed Incorporated Liposomes comprising an aminoglycoside for the treatment of pulmonary infections
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
AU2003257154A1 (en) * 2003-08-05 2005-03-07 Sepracor Inc. AMINO ACID AND PEPTIDE-MODIFIED FORMS OF GLUCOCORTICOIDS IN COMBINATION WITH ss2 ADRENERGIC AGONISTS
CA2631872C (en) 2005-12-08 2014-04-01 Transave, Inc. Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
NO331891B1 (no) * 2007-03-20 2012-04-30 Clavis Pharma Asa Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS
US20100196455A1 (en) 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
WO2013177226A1 (en) 2012-05-21 2013-11-28 Insmed Incorporated Systems for treating pulmonary infections
CA2891487A1 (en) 2012-11-29 2014-06-05 Insmed Incorporated Stabilized vancomycin formulations
LT3466432T (lt) 2014-05-15 2020-12-28 Insmed Incorporated Būdai, skirti plaučių netuberkuliozinėms mikobakterinėms infekcijoms gydyti
KR101961484B1 (ko) * 2016-01-08 2019-03-22 최규선 생콩 탈피장치
EP3773505A4 (en) 2018-03-30 2021-12-22 Insmed Incorporated PROCESS FOR THE CONTINUOUS MANUFACTURING OF LIPOSOMAL MEDICINAL PRODUCTS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE378109B (sv) * 1972-05-19 1975-08-18 Bofors Ab
GB1523965A (en) * 1976-03-19 1978-09-06 Ici Ltd Pharmaceutical compositions containing steroids
GB1575343A (en) * 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds
CH621479A5 (sv) * 1977-08-05 1981-02-13 Battelle Memorial Institute
FR2416008A1 (fr) * 1978-02-02 1979-08-31 Oreal Lyophilisats de liposomes
JPS609726B2 (ja) * 1980-05-15 1985-03-12 株式会社 ミドリ十字 ステロイド製剤
HU182775B (en) * 1981-10-15 1984-03-28 Richter Gedeon Vegyeszet Process for preparing new 3-chloro-pregnane derivatives
DE3228629A1 (de) * 1982-07-31 1984-02-02 Reifenrath, Rainer Richard Otto, Dr., 3104 Unterlüß Pharmazeutisches erzeugnis zur behandlung der atemwege und verfahren zu seiner herstellung
GB2135647A (en) * 1983-02-15 1984-09-05 Squibb & Sons Inc Method of preparing liposomes and products produced thereby

Also Published As

Publication number Publication date
ES8705895A1 (es) 1987-05-16
EG17462A (en) 1991-03-30
IE851892L (en) 1986-01-30
IE58074B1 (en) 1993-06-30
KR930000045B1 (ko) 1993-01-06
ZA855032B (en) 1986-03-26
AU4530785A (en) 1986-02-06
ATE60990T1 (de) 1991-03-15
SG69093G (en) 1993-08-06
HUT39460A (en) 1986-09-29
HU196827B (en) 1989-01-30
CS254342B2 (en) 1988-01-15
PT80884A (en) 1985-08-01
NO168042B (no) 1991-09-30
ES8704969A1 (es) 1987-04-16
FI84914C (sv) 1992-02-10
NO168042C (no) 1992-01-08
HK78293A (en) 1993-08-13
US4693999A (en) 1987-09-15
PH21644A (en) 1988-01-13
DK164509C (da) 1992-11-23
PL254681A1 (en) 1986-11-18
IS3026A7 (is) 1986-01-31
CA1250830A (en) 1989-03-07
EP0170642A3 (en) 1986-10-29
ES557143A0 (es) 1987-05-16
FI852932L (fi) 1986-01-31
NO852672L (no) 1986-01-31
PL145673B1 (en) 1988-10-31
DD248055A5 (de) 1987-07-29
DK164509B (da) 1992-07-06
DD236535A5 (de) 1986-06-11
YU45735B (sh) 1992-07-20
NZ212861A (en) 1989-01-27
JPS6143110A (ja) 1986-03-01
KR860000863A (ko) 1986-02-20
DK336385A (da) 1986-01-31
FI852932A0 (fi) 1985-07-29
CY1731A (en) 1994-05-06
JPH0459297B2 (sv) 1992-09-21
ES545651A0 (es) 1987-04-16
FI84914B (fi) 1991-10-31
EP0170642B1 (en) 1991-02-27
DK336385D0 (da) 1985-07-24
PT80884B (pt) 1987-11-30
AU582173B2 (en) 1989-03-16
EP0170642A2 (en) 1986-02-05
SU1493111A3 (ru) 1989-07-07
YU123885A (en) 1988-02-29
IS1515B (is) 1992-11-04
DE3581856D1 (de) 1991-04-04

Similar Documents

Publication Publication Date Title
SE8403905D0 (sv) Liposomes and steroid esters
ATE103585T1 (de) Polyamin-derivate als antineoplastische wirkstoffe.
ES452550A1 (es) Procedimiento para la preparacion de derivadas de acidos fe-noxialcohilcarboxilicos.
KR880013562A (ko) 7-티아프로스타글란딘e₁ 또는 그의 유도체를 함유하는 당뇨병치료 조성물
TH3073EX (th) ไลโพโซมที่มีสเทอรอยด์เอสเทอร์
ES2058315T3 (es) Compuestos eficaces contra insuficiencia cerebral.
DE2963019D1 (en) Novel 3-beta-amino-2-beta-hydroxy steroids of the androstane, oestrane and pregnane series, processes for their preparation and pharmaceutical compositions
DE3175939D1 (en) Use of gamma-piperidino-butyrophenones for the preparation of medicaments for treating diarrhoea
TH3073A (th) ไลโพโซมที่มีสเทอรอยด์เอสเทอร์
NO167382C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-hydroxy-4-(substituerte alkenyl)cyklohexancarboxylsyrer.
KR890001527A (ko) 에이즈 및 에이즈 관련 복합증상의 억제를 위한 아바콘, 아바롤 및 그 유도체의 용도